On August 1, 2021, Immunome, Inc. and Michael J. Morin, Ph.D. entered into a Second Amended and Restated Employment Agreement, which amended and superseded the Amended and Restated Employment Agreement between the Company and Dr. Morin dated September 24, 2020. In connection with the execution and delivery of the Employment Agreement, Dr. Morin resigned from his positions as Chief Scientific Officer and Executive Vice President of the Company.